(PRWEB) January 20, 2013
The report "Global Transfection Technologies Market - (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) And Types (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) (2012 – 2017) " defines and segments the global Transfection market with analysis of forecasting of the global revenue and applications revenue for transfection products. It also identifies driving and restraining factors for the global transfection market with analysis of trends, opportunities, challenges, strengths, weakness and threats. The market segmentation and revenue forecasting has been done region wise(incliding North America, Europe, Asia and Rest of the World), and also on the basis of application, products and technologies.
Browse 9 market data tables and 26 figures spread through 130 slides and in-depth TOC on "Global Transfection Technologies Market - (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) And Types (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) (2012 – 2017)."
Early buyers will receive 10% customization on reports.
Transfection technologies are widely used in cell research, recombinant protein production, drug discovery, gene therapy and therapeutics. The growing market for recombinant protein boosts the development of transfection technologies; biopharmaceutical companies are looking for technologies in hard to transfect cells in order to maximize production and product efficiency. There is demand for methods in hard to transfect cells which are the key for future applications and growth.
Cost has been a major factor in the transfection technology market. The market is segmented based on the technologies, where Bio-chemical based methods hold the major share in the market because of its cost advantage and simplicity over other technologies. Physical based methods are growing at a healthy pace because of its ability to transfect hard to transfect cells, while the viral mediated methods are growing at a steady phase.
The key growth area of transfection products is the application in therapeutic area, where transfection is effectively used in treatment of cancer and other genetic disorders. Growth in gene therapy is also driving the transfection market. Gene therapy promises to cure various diseases and disorders, and is one of the growing application in therapeutic segments with four approved drugs being in market. Electrochemotherapy is another upcoming therapeutic method being tested widely in Europe and America for treating cutaneous and sub-cutaneous tumors.
The global market for transfection products was estimated to be worth US $385 million in 2012 and is expected to reach US $601 million by 2017, growing at a CAGR of 9.32% from 2012 to 2017.
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. M&M covers thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Read the full story at http://www.prweb.com/releases/transfection/technologies-market/prweb10338301.htm.
Copyright©2012 Vocus, Inc.
All rights reserved